‘There is no evidence’ Omicron is smaller than Delta, say UK researchers

Covid-19 cases in the UK rose to 93,000 by the third day in a row on Friday, as investigators warned that there was “no evidence” that Omicron was milder than the Delta nation.

The Imperial College London research, which analyzed UK disease data, casts doubt on the expectations of some experts, according to reports from healthcare providers in South Africa, that changes in the virulence of new mutations could reduce the stress on health systems.

An emergency cabinet meeting will be held on Saturday to review Omicron’s latest information, which one insider in the state described as “very black”. Someone described the threat of change as “alarming possibility”.

Coronavirus vaccines can provide about 85% protection against Omicron’s dangerous infections, as well as more than 90% protection against death, 60 days after delivery, the study found.

But Prof Azra Ghani, an epidemiologist at Imperial and co-author of the study, said the high number of cases that occurred from Omicron could result in “the number of people who need to be hospitalized”.

A government official said the concern was growing hospitals in London, epicenter of Omicron in the UK. “It simply came to our notice then. . . and we are closely monitoring London hospitals, “the man said.

In extreme cases, the daily death toll from Omicron waves could be in the thousands, beyond the last five years, the study said. But Ghani emphasized that the figures were “an indication of the need to take action and not to predict”.

Several other prohibition decisions, dubbed “Plan C”, were made by officials and presented to Boris Johnson on Friday. Those familiar with the plan said it came from “a slight improvement in pushing people, to the point of closure”.

About 93,045 people were tested within the last 24 hours, about 60 percent from the 58,194 cases reported last week. So far, an inspiring 861,306 shots have been issued in the UK nationwide, indicating a well-known release date.

“It’s 50:50 right now if the course we are taking will be Scottish guidance,” a government official said, echoing Nicola Sturgeon’s call to limit contact with the three families, “based on new approaches that need to be commemorated by parliament.”

Allies of Johnson said it wants to continue with “guidance” rather than impose greater sanctions. “Boris is concerned about disrupting two consecutive Christmas holidays, but he also needs to be aware of the dangers we face,” he said.

Chancellor Rishi Sunak will be on the weekend to consider calls from business for a new support package for restaurants and restaurants that collapse businesses where many people ban Christmas meetings.

Prof Neil Ferguson, a UK government science adviser who led the Imperial study, said “time is of the essence” if the government wants to make “other decisions” on certain restrictions, adding that “they should be made next week. Or two have a major impact”.

“If you have enough cases per day, the number of hospitals we think could be a challenge for any hospital,” he said.

Ferguson said the data did not provide “a strong indication of Omicron’s decline against Delta”. But he added that a “definite verdict” could be made “within a week” as more is reflected in the Omicron-related laws, which are increasingly “very” in London and Manchester.

The findings were based on a review of 120,000 Delta cases and 15,000 Omicron suspects, as well as 24 Omicron hospitals and more than 1,000 Delta hospitals. Preliminary studies have shown that people with Omicron virus can show symptoms and need medical attention like Delta patients.

Ghani said the results show “the need to provide extra dose”. Without additional dosage, protection against dermatitis with Omicron could be reduced to about 20 percent for Oxford / AstraZeneca vaccine holders, and 40 percent for BioNTech / Pfizer by six months after the second dose.

However, the authors stated that this was very difficult and that the reduction could be offset by a longer period of protection provided by T-cells and B-cells, the second line of defense.

By six months after the second dose, AstraZeneca Double Dosage provides protection between zero and 5 percent for symptomatic infections, and BioNTech / Pfizer Dual Rate about 20 percent, research has shown, dropping from about 30 to 60 percent. according to Delta.

The study also found that Omicron placed a five-fold increased risk compared to the Delta crisis, meaning that the risk of reincarnation could be as low as 19 percent, down from 85 percent before Omicron struck.